The immune response may be considered as a complex metabolic process initiated by an antigenic substance and resulting in the formation of highly specific proteins. The mechanisms underlying this response are not clearly understood, but it is evident that the nucleus of antibody forming cells as well as their cytoplasm participate (1) . Following the administration of antigenic material to experimental animals, striking morphologic and biochemical changes occur within the antibody forming tissues (2) . The structural alterations include hypertrophy and cellular proliferation, while the biochemical changes are reflected by increased nitrogen, desoxyribose nucleic acid (DNA) and ribonucleic acid (RNA) contents of these tissues. These changes occur during the primary and secondary immune responses 1 as well as after the stimulation of regional lymph nodes by heterografts (3) . The increase in DNA content is largely due to cell multiplication, which begins within 48 hours after the injection of antigen. Increases in RNA, however, occur somewhat later, and the peak of cellular RNA concentration coincides closely with the peak of serum antibody titer (4, 5) . Studies such as these indicate that the formation of antibody is closely linked to nucleic acid metabolism.
In a previous publication we have shown that * Aided by grants from the United States Atomic Energy Commission Contract AT . 1 The primary response is an immunological reaction which follows the first exposure to an antigen. It is characterized by the relatively slow appearance of small quantities of antibody in the blood. The secondary response is an immunological reaction which occurs after re-exposure to an antigen. In contrast to the primary response, this reaction is rapid, large quantities of antibody are formed and antibodies are found in the blood over a long period of time.
a purine analog, 6-mercaptopurine (6-MP), prevents the formation of antibodies by hyperimmunized rabbits (6) . In this report we will present further studies concerning the mechanism of action of 6-MP on the immune responses of rabbits. These responses were studied in vivo by determining rates of antigen disappearance using the isotope technique of Talmage, Dixon, Bukantz and Dammin (7) and by measuring antibody appearance by the ammonium sulfate fractionation method of Farr (8) and the tannic acid hemagglutination of Stavitsky (9) . It will be shown that 6-MP can completely block the primary immune response, while that dose of the drug which prevents the appearance of the primary response delays, but does nlot prevent, the onset of the secondary response. 6-Mercaptopurine. This compound was supplied as an amorphous yellow powder, insoluble in water, but quite soluble in dilute alkali. Fresh solutions were prepared daily by dissolving pre-weighed aliquots of 6-MP in 1.0 N NaOH (1 ml. of alkali per 100 mg. of 6-MP); the resulting solution was diluted to the desired concentration with normal saline. All injections of the drug were given intramuscularly. about 18 days after the injection of antigen and thereafter began to decline.
All groups of animals treated with 6-MP behaved quantitatively differently from the control group, except the group treated with 6 mg. per Kg. per day, which differed both quantitatively and qualitatively from the untreated animals. This latter group will be discussed separately. The immune disappearance phase developed in each of the other groups of treated animals, but the time of onset was delayed in proportion to the dose of 6-MP administered. Thus, in the group given 1 mg. per Kg. per day the accelerated portion of the curve began on the ninth day; those animals treated with 2 mg. per Kg. per day developed this phase on the twelfth day; while the group in which 3 mg. per Kg. per day was given responded on the fourteenth day. This relationship between dose and suppression of the immune response was arbitrarily expressed as a percentage 100 10 corresponding closely to the results obtained by Talmage and associates (7), and by Dixon (10) . During the first 24 hours about two-thirds of the initial radioactivity disappeared from the serum. The remaining one-third then showed a logarithmic decay curve similar to that seen with other circulating proteins. However, on the seventh day after antigen injection an accelerated disappearance phase began, and within three days all traces of radioactivity were gone from the circulation. Coincident with this accelerated disappearance of antigen ("immune disappearance phase") there was a sharp rise in the percentage of HSA-I bound to globulin, indicating the appearance of circulating antigen-antibody complexes. Nine days after antigen injection, practically all of the detectable isotope was in the globulin fraction. Twelve days after the administration of the antigen the tannic acid hemagglutination tests were positive, indicating the presence of "free" humoral antibody. Antibody titers reached their peaks of "immunological efficiency" by assuming the untreated animals to be 100 per cent efficient; the efficiencies of the treated groups were calculated according to the formula: Per cent immunological efficiency induction period of controls X100 induction period of treated group This relationship is illustrated in Figure 4 . It can be seen that a linear relationship exists between the dose of 6-MP and the arbitrary "immunological efficiency."
The rabbits treated with 6-MP in a dose of 6 mg. per Kg. per day did not develop the third phase of antigen disappearance. After initial equilibration, the antigen decayed logarithmically until the sixteenth day after its injection; further determinations of serum radioactivity were not done because the very small amount of isotope remaining precluded accurate count. At no time did antigen-antibody complexes appear. Humoral antibodies were not detected during the 25 days of the study. Further evidence that antibody production was completely blocked was obtained by reinjecting this group with a second dose of HSA-I. These results, which will be reported in detail elsewhere (11) , indicate that antibody was absent from the blood of these animals at the time of the second injection of antigen.
The secondary response.
The results of these experiments are illustrated in Figures 5 and 6 and the data for each rabbit are listed in Tables IV, V and VI. Radiolabeled antigen disappeared from the circulation of the control group in the three distinct phases previously described. The onset of the immune disappearance phase, however, occurred much earlier -on the third day after antigen injection, and by the fifth day no circulating antigen was detectable. On the fourth day most of the circulating antigen was bound to globulin as antigen-antibody complexes. Five days after the injection of antigen "free" humoral antibody was detected by the tannic acid hemagglutination method; titers quickly rose and by the twelfth day they were at their peak.
6-MP, when given in a dose of 3 mg. per Kg. per day, had no effect on the secondary response. However, when twice that dose was given the onset of the immune disappearance phase occurred in the seventh day rather than on the third day. "Free" antibody appeared on the ninth day and the tannic acid hemagglutination titers rose tlhereafter to a peak on the twenty-second day after antigen injection. Although the animals of this group eventually attained antibody titers equal to those of the control group, the rate of increase was more gradual than in the untreated animals. DISCUSSION Antibody formation has been suppressed by a number of agents, including X-radiation (12) , nitrogen mustard (13) , thorium dioxide (14) , cortisone (15) , vitamin deficiencies (16) , vitamin analogs (17), amino acid analogs (18) , and purine antagonists (6, (19) (20) (21) Althouigh the effects of 6-MP ( Figure 7 ) on iimmune responses are clearcut, its exact mode of action at the "biochemical level" is not well understood. There is much evidence to support the view that 6-MP acts as a nucleic acid antagonist, but the precise details of its action are ill defined. Its role in purine metabolism has been extensively investigated and it has been shown that 6-MP inhibits the incorporation of P32 into the nucleic acids of mouse tumors (22) ; not only is the de novo synthesis of nucleic acids by Sarcoma 180 cells suppressed by this agent (23) , but radiolabeled 6-MP is probably synthesized into the nucleic acid molecules of certain cells (24) .
Other studies have demonstrated that the incorporation of hypoxanthine into nucleic acids of viruses is blocked by this agent (25) . 6-MP probably acts as a nonspecific purine antagonist, since its inhibitory action on bacterial growth can be reversed by any of the natural purines (26) . Work with 6-MP resistant mutants of L. casel suggested that 6-MP interferes with the conversion of adenine to guanine via hypoxanthine (27) ; this conclusion was later supported by experiments done with C14 labeled adenine which denmonstrated that the 6-AMP resistant mutant lacks a pathway for converting hypoxanthine to nucleic acid purines (28) . Skipper came to similar conclusions concerniing this action of 6-MP from his studies of the intestinal tissues of mice treated xvith this compound (23). 6-MP may also act on nucleic acid metabolism by interfering with normal purine interconversion mechanisms (29) or by competing with enzymes responsible for the conjugation of purine bases with ribose sugars, thereby forming ribosides and ribotides (30) ).
The widespread occurrence of purine moieties in nature has led to the investigation of the effect of 6-MP on systems other than nucleic acid metabolism. Tlhus, it has been found that the in vitro antimitotic activity of 6-MP can be overcome by coenzyme A, an adenine containing derivative of pantothenic acid essential in lipid metabolism (31); the increase in tissue diphosphopyridine nucleotide (DPN) that usually appears after the injection of nicotinamide into mice is prevented by treatment of these animals with 6-MP (32); amino acid (glutamate) incorporation into pea-seedling protein has been blocked with 6-MP (33); diminished amounts of adenosine triphosphate (ATP) have been found in tumorbearing mice treated with this compound (34) ; and interference with hexokinase by 6-MP has been shown both in vivo and in vitro (35, 36) .
Whether the demonstrated effects of 6-MP on nucleic acid metabolism are the primary actions of this drug, or whether it acts through interference with other systems, such as ATP or hexokinase, and only secondarily induces biochemical lesions in nucleic acids, are speculative points. In any event, it is probable that the principle observable effect of 6-MP is on nucleic acid metabolism.
Certain conclusions can be drawn concerning the effect of 6-MP at the "immunological level."
